214 related articles for article (PubMed ID: 27744035)
1. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
Günday Türeli N; Türeli AE; Schneider M
Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035
[TBL] [Abstract][Full Text] [Related]
2. Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections.
Günday Türeli N; Torge A; Juntke J; Schwarz BC; Schneider-Daum N; Türeli AE; Lehr CM; Schneider M
Eur J Pharm Biopharm; 2017 Aug; 117():363-371. PubMed ID: 28476373
[TBL] [Abstract][Full Text] [Related]
3. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
[TBL] [Abstract][Full Text] [Related]
4. Counter-ion complexes for enhanced drug loading in nanocarriers: Proof-of-concept and beyond.
Günday Türeli N; Türeli AE; Schneider M
Int J Pharm; 2016 Sep; 511(2):994-1001. PubMed ID: 27520732
[TBL] [Abstract][Full Text] [Related]
5. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
[TBL] [Abstract][Full Text] [Related]
6. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles.
Fonte P; Lino PR; Seabra V; Almeida AJ; Reis S; Sarmento B
Int J Pharm; 2016 Apr; 503(1-2):163-73. PubMed ID: 26972381
[TBL] [Abstract][Full Text] [Related]
7. Improved effect of amikacin-loaded poly(D,L-lactide-co-glycolide) nanoparticles against planktonic and biofilm cells of Pseudomonas aeruginosa.
Sabaeifard P; Abdi-Ali A; Gamazo C; Irache JM; Soudi MR
J Med Microbiol; 2017 Mar; 66(2):137-148. PubMed ID: 28260589
[TBL] [Abstract][Full Text] [Related]
8. Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Verheyden L; Ludwig A
Int J Pharm; 2004 May; 275(1-2):171-87. PubMed ID: 15081148
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.
Dillen K; Vandervoort J; Van den Mooter G; Ludwig A
Int J Pharm; 2006 May; 314(1):72-82. PubMed ID: 16600538
[TBL] [Abstract][Full Text] [Related]
10. Smart lipid nanoparticles containing levofloxacin and DNase for lung delivery. Design and characterization.
Islan GA; Tornello PC; Abraham GA; Duran N; Castro GR
Colloids Surf B Biointerfaces; 2016 Jul; 143():168-176. PubMed ID: 27003467
[TBL] [Abstract][Full Text] [Related]
11. Polymer assisted entrapment of netilmicin in PLGA nanoparticles for sustained antibacterial activity.
Kolate A; Kore G; Lesimple P; Baradia D; Patil S; Hanrahan JW; Misra A
J Microencapsul; 2015; 32(1):61-74. PubMed ID: 25238317
[TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.
Jeong YI; Na HS; Seo DH; Kim DG; Lee HC; Jang MK; Na SK; Roh SH; Kim SI; Nah JW
Int J Pharm; 2008 Mar; 352(1-2):317-23. PubMed ID: 18160236
[TBL] [Abstract][Full Text] [Related]
13. Ultrasmall TPGS-PLGA Hybrid Nanoparticles for Site-Specific Delivery of Antibiotics into
Wan F; Bohr SS; Kłodzińska SN; Jumaa H; Huang Z; Nylander T; Thygesen MB; Sørensen KK; Jensen KJ; Sternberg C; Hatzakis N; Mørck Nielsen H
ACS Appl Mater Interfaces; 2020 Jan; 12(1):380-389. PubMed ID: 31804792
[TBL] [Abstract][Full Text] [Related]
14. Hydrophobic ion pairing of a minocycline/Ca(2+)/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release.
Holmkvist AD; Friberg A; Nilsson UJ; Schouenborg J
Int J Pharm; 2016 Feb; 499(1-2):351-357. PubMed ID: 26773599
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
[TBL] [Abstract][Full Text] [Related]
16. Alginate lyase immobilized chitosan nanoparticles of ciprofloxacin for the improved antimicrobial activity against the biofilm associated mucoid P. aeruginosa infection in cystic fibrosis.
Patel KK; Tripathi M; Pandey N; Agrawal AK; Gade S; Anjum MM; Tilak R; Singh S
Int J Pharm; 2019 May; 563():30-42. PubMed ID: 30926526
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
18. Amikacin loaded PLGA nanoparticles against Pseudomonas aeruginosa.
Sabaeifard P; Abdi-Ali A; Soudi MR; Gamazo C; Irache JM
Eur J Pharm Sci; 2016 Oct; 93():392-8. PubMed ID: 27575877
[TBL] [Abstract][Full Text] [Related]
19. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
20. The effect of freeze-drying with different cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactide-glycolide) nanoparticles.
Bozdag S; Dillen K; Vandervoort J; Ludwig A
J Pharm Pharmacol; 2005 Jun; 57(6):699-707. PubMed ID: 15969924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
